EN
HI
Eris Lifesciences share price chart
Eris Lifesciences Share Key Metrics
Volume
23389.00
Market Cap
18404.50 CR
LTQ@LTP
1@1321.00
ATP
1322.15
Var Margin
15.87 %
Circuit Range
1062.6-1593.8
Delivery %
52.93 %
Value
3.09 CR
ASM/GSM
No
Market Lot
1
Summary
ERIS stock price is ₹1321 as of 24 Aug, 2026. The stock intraday movement has stayed between ₹1312.40 and ₹1337.40, while Eris Lifesciences share price 52 week high low is ₹1200.00 & ₹1818.80.
In terms of trading activity, ERIS share price has recorded a volume of 23,389 shares. The Eris Lifesciences has a market cap of ₹138567256. The stock’s Average Traded Price (ATP) stands at ₹1322.15, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1321.00.
The Eris Lifesciences upper circuit limit is ₹1593.80 & The Eris Lifesciences lower circuit limit is ₹1062.60, with a Value of ₹3.09 CR. The Delivery Percentage for the day is 52.93%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Eris Lifesciences Fundamentals
P/E Ratio
28.53
P/B Ratio
4.54
Div. Yield
0.54
Sector P/E
68.51
Sector P/B
3.33
Sec. Div. Yield
0.51
Eris Lifesciences Resistance and Support
Pivot 1323
Resistance
First Resistance
1342
Second Resistance
1355.8
Third Resistance
1374.8
Support
First Support
1309.2
Second Support
1290.2
Third Support
1276.4
Eris Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 24 2026 | 1335 | 1321 | -0.54% | 1337.4 | 1312.4 |
| Fri Aug 21 2026 | 1330.09 | 1328.19 | 0.17% | 1336.8 | 1304 |
| Thu Aug 20 2026 | 1350 | 1326 | -1.65% | 1351.3 | 1322.59 |
Eris Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-29 | Quarterly Results |
| 2026-05-20 | Audited Results & Interim Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-24 | Preferential issue of shares |
| 2025-11-12 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-07 | Interim Dividend |
| 2025-02-04 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
| 2024-08-02 | Quarterly Results |
Eris Lifesciences News
Eris Lifesciences Ltd - 540596 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015, - Availing Working Capital Term Loan From Axis Bank
Eris Lifesciences has drawn down a working capital term loan amounting to Rs.64.40 crore from Axis Bank Limited. This loan is intended to meet other short-term liabilities, and the company stated its aggregate debt level remains unchanged.
Aug 06 2026 09:38:44
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Eris Lifesciences announced that the recording of its Q1 FY27 earnings conference call, held on July 29, 2026, is now available. Investors can access the audio via the financials section on the company's website for detailed insights into the quarter's performance.
Jul 29 2026 18:38:48
Eris Lifesciences Management
| Name | Position |
|---|---|
| Milind Talegaonkar | Company Secretary & Compliance Officer |
| Krishnakumar Vaidyanathan | Whole Time Director & COO |
Eris Lifesciences Similar Stocks
Acutaas Chemicals Ltd.
3210.20
41.20 (1.30%)
Pfizer Ltd.
4899.90
-78.30 (1.57%)
Granules India Ltd.
859.55
1.40 (0.16%)
Caplin Point Laboratories Ltd.
2500.00
-60.80 (2.37%)
Astrazeneca Pharma India Ltd.
7285.00
-130.50 (1.76%)
Cohance Lifesciences Ltd.
451.30
-11.70 (2.53%)
Onesource Specialty Pharma Ltd.
1523.00
-12.00 (0.78%)
Poly Medicure Ltd.
1742.60
23.20 (1.35%)
Concord Biotech Ltd.
1535.90
-35.40 (2.25%)
Alembic Pharmaceuticals Ltd.
816.90
-4.85 (0.59%)
Eris Lifesciences FAQs
The Buying Price of Eris Lifesciences share is 1321 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Eris Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Eris Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Eris Lifesciences shares is 28.53. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Eris Lifesciences shares is 4.54. Useful to assess the stock's value relative to its book value.
To assess Eris Lifesciences’s valuation compare Sector P/E, P/B which are 68.51 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Eris Lifesciences is 18404.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Eris Lifesciences share price is 1818.80 & 1200.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Eris Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
